2seventy bio, Inc. – NASDAQ:TSVT

2seventy bio stock price today

$5
+1.95
+63.93%
Financial Health
0
1
2
3
4
5
6
7
8
9

2seventy bio stock price monthly change

-31.31%
month

2seventy bio stock price quarterly change

-31.31%
quarter

2seventy bio stock price yearly change

-31.00%
year

2seventy bio key metrics

Market Cap
152.18M
Enterprise value
199.46M
P/E
-1.29
EV/Sales
7.38
EV/EBITDA
-3.24
Price/Sales
0.01
Price/Book
N/A
PEG ratio
N/A
EPS
-4.35
Revenue
71.20M
EBITDA
-182.80M
Income
-223.22M
Revenue Q/Q
-70.12%
Revenue Y/Y
-42.89%
Profit margin
-287.93%
Oper. margin
-539.33%
Gross margin
98.64%
EBIT margin
-539.33%
EBITDA margin
-256.74%
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

2seventy bio stock price history

2seventy bio stock forecast

2seventy bio financial statements

2seventy bio, Inc. (NASDAQ:TSVT): Profit margin
Jun 2023 36.04M -42.08M -116.76%
Sep 2023 12.03M -71.63M -595.3%
Dec 2023 10.68M -56.82M -531.84%
Mar 2024 12.43M -52.67M -423.59%
2seventy bio, Inc. (NASDAQ:TSVT): Analyst Estimates
Mar 2024 12.43M -52.67M -423.59%
Sep 2025 19.18M -4.71M -24.57%
Oct 2025 14.4M -11.45M -79.55%
Dec 2025 14.5M -13.01M -89.78%
  • Analysts Price target

  • Financials & Ratios estimates

2seventy bio, Inc. (NASDAQ:TSVT): Debt to assets
Jun 2023 705713000 338.21M 47.93%
Sep 2023 640806000 334.38M 52.18%
Dec 2023 565426000 310.12M 54.85%
Mar 2024 511051000 303.61M 59.41%
2seventy bio, Inc. (NASDAQ:TSVT): Cash Flow
Jun 2023 -32.66M -64.88M 128K
Sep 2023 -21.51M 16.05M -75K
Dec 2023 -63.59M 47.89M 253K
Mar 2024 -41.87M 21.83M 386K

2seventy bio alternative data

2seventy bio, Inc. (NASDAQ:TSVT): Employee count
Aug 2023 425
Sep 2023 425
Oct 2023 425
Nov 2023 425
Dec 2023 425
Jan 2024 425
Feb 2024 425
Mar 2024 274
Apr 2024 274
May 2024 274
Jun 2024 274
Jul 2024 274

2seventy bio other data

78.11% -21.89%
of TSVT is owned by hedge funds
29.97M -4.64M
shares is hold by hedge funds

2seventy bio, Inc. (NASDAQ:TSVT): Insider trades (number of shares)
Period Buy Sel
Jan 2024 0 135305
Mar 2024 817377 63151
May 2024 0 15
Jun 2024 0 1816
Jul 2024 0 26
Aug 2024 0 7829
Oct 2024 0 1909
Nov 2024 0 3900
Dec 2024 0 2287
Transaction Date Insider Security Shares Price per share Total value Source
Sale
SNOW JESSICA officer: See Remarks
Common Stock 2,287 $3.23 $7,394
Sale
MAUS MARCELA V. director
Common Stock 3,900 $3.38 $13,182
Sale
SNOW JESSICA officer: See Remarks
Common Stock 679 $4.65 $3,157
Sale
EATWELL VICTORIA officer: Chief Financial Officer
Common Stock 1,230 $4.65 $5,718
Sale
SNOW JESSICA officer: See Remarks
Common Stock 7,816 $4.32 $33,757
Sale
EATWELL VICTORIA officer: Chief Financial Officer
Common Stock 13 $3.99 $52
Sale
EATWELL VICTORIA officer: Chief Financial Officer
Common Stock 12 $4.02 $48
Sale
SNOW JESSICA officer: See Remarks
Common Stock 14 $4.02 $56
Sale
EATWELL VICTORIA officer: Chief Financial Officer
Common Stock 1,167 $4.18 $4,880
Sale
SNOW JESSICA officer: See Remarks
Common Stock 649 $4.18 $2,714
Wednesday, 4 December 2024
zacks.com
Saturday, 16 November 2024
accesswire.com
Thursday, 14 November 2024
accesswire.com
Tuesday, 12 November 2024
accesswire.com
seekingalpha.com
zacks.com
Sunday, 10 November 2024
prnewswire.com
Friday, 8 November 2024
accesswire.com
Wednesday, 6 November 2024
accesswire.com
Monday, 4 November 2024
accesswire.com
businesswire.com
Saturday, 2 November 2024
prnewswire.com
Thursday, 31 October 2024
accesswire.com
Tuesday, 29 October 2024
accesswire.com
Sunday, 27 October 2024
accesswire.com
Friday, 25 October 2024
prnewswire.com
Wednesday, 23 October 2024
accesswire.com
Saturday, 19 October 2024
accesswire.com
Thursday, 17 October 2024
prnewswire.com
Tuesday, 15 October 2024
accesswire.com
Sunday, 13 October 2024
accesswire.com
Friday, 11 October 2024
accesswire.com
accesswire.com
Thursday, 10 October 2024
accesswire.com
accesswire.com
Wednesday, 9 October 2024
prnewswire.com
globenewswire.com
accesswire.com
accesswire.com
Tuesday, 8 October 2024
businesswire.com
  • What's the price of 2seventy bio stock today?

    One share of 2seventy bio stock can currently be purchased for approximately $5.

  • When is 2seventy bio's next earnings date?

    Unfortunately, 2seventy bio's (TSVT) next earnings date is currently unknown.

  • Does 2seventy bio pay dividends?

    No, 2seventy bio does not pay dividends.

  • How much money does 2seventy bio make?

    2seventy bio has a market capitalization of 152.18M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 9.72% to 100.39M US dollars.

  • What is 2seventy bio's stock symbol?

    2seventy bio, Inc. is traded on the NASDAQ under the ticker symbol "TSVT".

  • What is 2seventy bio's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of 2seventy bio?

    Shares of 2seventy bio can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does 2seventy bio have?

    As Jul 2024, 2seventy bio employs 274 workers.

  • When 2seventy bio went public?

    2seventy bio, Inc. is publicly traded company for more then 3 years since IPO on 3 Nov 2021.

  • What is 2seventy bio's official website?

    The official website for 2seventy bio is 2seventybio.com.

  • Where are 2seventy bio's headquarters?

    2seventy bio is headquartered at 60 Binney Street, Cambridge, MA.

  • How can i contact 2seventy bio?

    2seventy bio's mailing address is 60 Binney Street, Cambridge, MA and company can be reached via phone at +33 94999300.

2seventy bio company profile:

2seventy bio, Inc.

2seventybio.com
Exchange:

NASDAQ

Full time employees:

274

Industry:

Biotechnology

Sector:

Healthcare

2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a collaboration arrangement with Bristol-Myers Squibb Company. The company was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.

60 Binney Street
Cambridge, MA 02142

CIK: 0001860782
ISIN: US9013841070
CUSIP: 901384107